---
figid: PMC3888279__jnci.j_djt201_f0003
figlink: /pmc/articles/PMC3888279/figure/F3/
number: F3
caption: Regulation of hypoxia-inducible factor (HIF)–α expression or stabilization
  by pathways other than hypoxia. Heat shock protein 90 (HSP90) interacts directly
  with HIF-1α and promotes its stabilization (a) (). HSP90 inhibitors and histone
  acetylase inhibitors promote degradation of HIF-α in a von Hippel-Lindau protein
  (pVHL)–independent manner (). Another pathway is sumoylation of HIF-α (b), but there
  is disagreement as to whether this leads to increased or decreased HIF-α stability
  (). Another method of HIF regulation is reciprocal control of prolyl hydroxylase
  domain proteins (PHDs) and HIF-1α by the nuclear factor kappa B (NF-κB) signaling
  pathway linked to the activation of phosphoinositide 3-kinase (PI3K) and RAC-alpha
  serine/threonine-protein kinase (Akt) signaling (c) (,). Hypoxia-associated factor
  (HAF, known also as SART1800) is overexpressed in a variety of tumor types, and
  it binds to and ubiquitinates HIF-1α by an oxygen- and pVHL-independent mechanism
  and targets HIF-1α for proteasomal degradation (d) (). The tumor suppressor protooncogene
  p53 (p53) seems to provide a route for HIF-1α degradation in hypoxic cells (), and
  HIF-1α seems to promote p53 transcription [for a review, see ()]. An important negative
  regulator of p53 is the murine double minute 2 (MDM2) ubiquitin protein ligase (,).
  It was suggested that it promotes HIF-1α degradation by binding to the HIF-1α/p53
  complex (), but the formation of trimeric p53/MDM2/HIF-1α complexes is controversial
  (e) [for a review, see ()]. Conversely, the direct interaction of HIF-1α has been
  shown to increase HIF-1 activity and abundance in hypoxic cells (,). c-Myc = Myc
  proto-oncogene; CBP = cAMP-response element-binding protein; Cul2 = cullin 2; E2
  = E2 ubiquitin-conjugating enzyme; FIH = factor inhibiting HIF; HRE = hypoxia-responsive
  elements; EGF = epidermal growth factor; EGF-R = epidermal growth factor receptor;
  FGF-R = fibroblast growth factor receptor; HSP90 = heat shock protein 90; IGF =
  insulin-like growth factor; IGF1-R = insulin-like growth factor 1 receptor; NGF
  = nerve growth factor; p300 = histone acetyltransferase p300; RET = Ret proto-oncogene;
  Rbx1 = ring box protein 1; SSAT2 = spermidine/spermine N1-acetyltransferase 2; SUMO1
  = small ubiquitin-related modifier 1; TGFα = transforming growth factor alpha; UQ
  = ubiquitin; VEGF-R = vascular endothelial growth factor receptor.
pmcid: PMC3888279
papertitle: 'Hypoxia-Inducible Factor Signaling in Pheochromocytoma: Turning the Rudder
  in the Right Direction.'
reftext: Ivana Jochmanová, et al. J Natl Cancer Inst. 2013 Sep 4;105(17):1270-1283.
pmc_ranked_result_index: '223920'
pathway_score: 0.9673452
filename: jnci.j_djt201_f0003.jpg
figtitle: Regulation of hypoxia-inducible factor (HIF)–A expression or stabilization
  by pathways other than hypoxia
year: '2013'
organisms:
- Homo sapiens
ndex: 8ac8b4ec-dece-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3888279__jnci.j_djt201_f0003.html
  '@type': Dataset
  description: Regulation of hypoxia-inducible factor (HIF)–α expression or stabilization
    by pathways other than hypoxia. Heat shock protein 90 (HSP90) interacts directly
    with HIF-1α and promotes its stabilization (a) (). HSP90 inhibitors and histone
    acetylase inhibitors promote degradation of HIF-α in a von Hippel-Lindau protein
    (pVHL)–independent manner (). Another pathway is sumoylation of HIF-α (b), but
    there is disagreement as to whether this leads to increased or decreased HIF-α
    stability (). Another method of HIF regulation is reciprocal control of prolyl
    hydroxylase domain proteins (PHDs) and HIF-1α by the nuclear factor kappa B (NF-κB)
    signaling pathway linked to the activation of phosphoinositide 3-kinase (PI3K)
    and RAC-alpha serine/threonine-protein kinase (Akt) signaling (c) (,). Hypoxia-associated
    factor (HAF, known also as SART1800) is overexpressed in a variety of tumor types,
    and it binds to and ubiquitinates HIF-1α by an oxygen- and pVHL-independent mechanism
    and targets HIF-1α for proteasomal degradation (d) (). The tumor suppressor protooncogene
    p53 (p53) seems to provide a route for HIF-1α degradation in hypoxic cells (),
    and HIF-1α seems to promote p53 transcription [for a review, see ()]. An important
    negative regulator of p53 is the murine double minute 2 (MDM2) ubiquitin protein
    ligase (,). It was suggested that it promotes HIF-1α degradation by binding to
    the HIF-1α/p53 complex (), but the formation of trimeric p53/MDM2/HIF-1α complexes
    is controversial (e) [for a review, see ()]. Conversely, the direct interaction
    of HIF-1α has been shown to increase HIF-1 activity and abundance in hypoxic cells
    (,). c-Myc = Myc proto-oncogene; CBP = cAMP-response element-binding protein;
    Cul2 = cullin 2; E2 = E2 ubiquitin-conjugating enzyme; FIH = factor inhibiting
    HIF; HRE = hypoxia-responsive elements; EGF = epidermal growth factor; EGF-R =
    epidermal growth factor receptor; FGF-R = fibroblast growth factor receptor; HSP90
    = heat shock protein 90; IGF = insulin-like growth factor; IGF1-R = insulin-like
    growth factor 1 receptor; NGF = nerve growth factor; p300 = histone acetyltransferase
    p300; RET = Ret proto-oncogene; Rbx1 = ring box protein 1; SSAT2 = spermidine/spermine
    N1-acetyltransferase 2; SUMO1 = small ubiquitin-related modifier 1; TGFα = transforming
    growth factor alpha; UQ = ubiquitin; VEGF-R = vascular endothelial growth factor
    receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MDM2
  - EPAS1
  - ARNT2
  - HIF3A
  - HSP90AB1
  - HSP90B1
  - IGF1R
  - TRAP1
  - NFKB1
  - ARNT
  - ARNTL
  - FLT1
  - HIF1A
  - PIK3R4
  - FGFR2
  - FGFR4
  - FGFRL1
  - PIK3R3
  - NGF
  - TP53
  - OPN1LW
  - PIK3R6
  - PIK3R5
  - FLT4
  - KDR
  - FGFR1
  - FGFR3
  - PIK3CA
  - HIF1AN
  - PIK3CB
  - RBX1
  - EP300
  - TGFA
  - SUMO1
  - MYC
  - CUL2
  - PIK3CG
  - EGF
  - EGFR
  - PIK3CD
  - AKT1
  - RET
  - SAT2
  - AKT2
  - AKT3
  - Succinate
  - tyrosine
  - Cancer
genes:
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: HIF-a
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: HIF-B
  symbol: HIF_beta
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: HIF-a
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90AB1
  entrez: '3326'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90B1
  entrez: '7184'
- word: IGF1-R,
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: TRAP1
  entrez: '10131'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: VEGF-R,
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: HIF-a
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: HIF-B
  symbol: HIF_beta
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: HIF-B
  symbol: HIF_beta
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: FGF-R,
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: FGF-R,
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: FGF-R,
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: NGF,.)
  symbol: NGF
  source: hgnc_symbol
  hgnc_symbol: NGF
  entrez: '4803'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: (p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: CBP
  symbol: CBP
  source: hgnc_prev_symbol
  hgnc_symbol: OPN1LW
  entrez: '5956'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: VEGF-R,
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGF-R,
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: FGF-R,
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: FGF-R,
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: FIH1
  symbol: FIH1
  source: hgnc_alias_symbol
  hgnc_symbol: HIF1AN
  entrez: '55662'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Rbx1
  symbol: RBX1
  source: hgnc_symbol
  hgnc_symbol: RBX1
  entrez: '9978'
- word: p300
  symbol: p300
  source: hgnc_alias_symbol
  hgnc_symbol: EP300
  entrez: '2033'
- word: TGFa,
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: SUMO1
  symbol: SUMO1
  source: hgnc_symbol
  hgnc_symbol: SUMO1
  entrez: '7341'
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: Cul2
  symbol: CUL2
  source: hgnc_symbol
  hgnc_symbol: CUL2
  entrez: '8453'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: (EGF,
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGF-R)
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: (RET,
  symbol: RET
  source: hgnc_symbol
  hgnc_symbol: RET
  entrez: '5979'
- word: SSAT2
  symbol: SSAT2
  source: hgnc_alias_symbol
  hgnc_symbol: SAT2
  entrez: '112483'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
chemicals:
- word: Succinate
  source: MESH
  identifier: D013386
- word: tyrosine
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3888279__F3
redirect_from: /figures/PMC3888279__F3
figtype: Figure
---
